查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
富血小板血漿市場規模,份額和趨勢分析報告，按類型（純血小板富血漿,白細胞富血漿）,應用（骨科,運動醫學,美容外科）,用途,地區和細分市場預測2022-2030
市場調查報告書
商品編碼
1114099

富血小板血漿市場規模,份額和趨勢分析報告，按類型（純血小板富血漿,白細胞富血漿）,應用（骨科,運動醫學,美容外科）,用途,地區和細分市場預測2022-2030

Platelet Rich Plasma Market Size, Share & Trends Analysis Report By Type (Pure Platelet Rich Plasma, Leukocyte Rich), By Application (Orthopedics, Sports Medicine, Cosmetic Surgery), By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

富含血小板的血漿市場增長和趨勢

根據 Grand View Research, Inc. 的一份新報告，2022 年至 2030 年，全球富血小板血漿市場規模的複合年增長率將達到 15.11%，到 2030 年將達到 19 億。預計達到4000萬美元。

整容手術的興起、國內和國際體育賽事數量的增加以及血漿療法研究的擴大正在推動該行業的發展。此外，基於富血小板血漿 (PRP) 的療法的研發活動和監管批准是主要的市場驅動力。

目前，使用 PRP 治療運動損傷、骨科疾病和肌肉骨骼疾病的需求激增。 PRP 提供濃縮劑量的生長因子，可以顯著減少癒合所需的時間。 PRP 在再生醫學領域也有重要應用，可作為每位患者的定制產品，以加速傷口癒合和修復級聯。

富血小板血漿已在整形手術中開發出來，在利用人體自身的自然組織修復過程並改善形態和功能方面取得了可喜的成果。 PRP 療法的主要優點是易於使用、使用患者細胞進行廉價生產以及幾乎沒有副作用的風險。然而，治療耗時且需要多次治療。它還對皮膚再生、皮膚色素沉著、痤瘡疤痕治療和吸血鬼面部收緊皮膚有效。 PRP 用作毛髮移植補充劑，以幫助形成和維持毛囊。因此，富含血小板的血漿的廣泛使用有望推動行業增長。

此外，主要參與者正在實施併購、產品開發和業務擴展等戰略舉措以進入市場。 2021 年 9 月，Terumo BCT 擴大了在哥斯達黎加的業務，在迦太基的拉利馬開設了新的製造工廠，以擴大其在美國的客戶群。 2020年2月，EmCyte Inc.收購了擁有 Centrepid 血小板濃縮系統的 Cellmedix Holdings LLC。這擴大了公司的產品組合併提高了市場佔有率。

鑑於 COVID-19，由於供應鏈中斷、資源分配限制和患者獲取活動受阻，市場經歷了重大挫折。然而，到 2021 年 1 月，市場趨於穩定，供需繼續正常化，用戶和患者重新獲得富含血小板的血漿。

富血小板血漿市場報告亮點

按類型劃分，純富含血小板的血漿部分將在 2021 年擁有超過 50.0% 的最大收入份額，原因是其在各個治療領域的廣泛使用以及全球對標籤外使用的需求不斷增長。

按應用劃分，由於調查 PRP 在骨科各種應用中的研究數量激增，骨科領域在 2021 年佔據了市場主導地位。然而，其他領域，如皮膚科、運動醫學和潰瘍癒合預計在預測期內將以更快的速度增長

醫院最終用途部門在 2021 年佔最大的收入份額。這可能是由於近年來提供基於 PRP 治療的醫院數量增加以及膝關節骨關節炎病例數量增加所致

由於 RPP 的廣泛使用、對基於 PRP 的療法的認識不斷提高以及骨科疾病的發病率不斷上升，北美在 2021 年主導了全球市場。

由於整容手術的增加和醫療旅遊業的增長，預計亞太地區未來將顯著增長。

內容

第一章調查方法及範圍

  • 調查方法
  • 調查假設
    • 估計/預測時間表
  • 信息採購
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 輔助信息
    • 初步調查
    • 初步調查的內容
  • 信息或數據分析
    • 富血小板血漿 (PRP) 市場：細分市場收入和增長分析
    • 運動醫學市場：細分收入和增長分析
    • 基於富血小板血漿 (PRP) 的潰瘍治療市場：細分市場收入和增長分析
      • 基於富血小板血漿 (PRP) 的潰瘍癒合市場：細分定義
      • 不癒合潰瘍
      • 糖尿病潰瘍
      • 壓瘡
      • 壞疽性膿皮病
      • 靜脈潰瘍
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算國別市場
  • 市場：CAGR 計算
  • 輔助信息列表
  • 主要信息列表
  • 目的

第 2 章市場定義

第 3 章執行摘要

  • 市場展望
  • 市場概覽

第 4 章宿主細胞污染物檢測市場變量、趨勢和範圍

  • 市場趨勢和前景
  • 市場細分和範圍
  • 市場驅動因素分析
    • 骨科疾病和運動損傷的發病率不斷上升
    • 對檢測宿主細胞污染進行更嚴格的監管
    • 擴展富血小板血漿的醫療應用
    • 增加基於 PRP 的傷口癒合的循證研究
  • 市場約束分析
    • 與 PRP 產品相關的高成本
  • 按因素（政法、經濟、技術）進行 SWOT 分析
  • 波特五力分析
  • COVID-19 影響分析
  • 繪製滲透率和增長前景

第 5 章富含血小板的血漿市場 - 細分分析，按類型，2018-2030 年（百萬美元）

  • 富血小板血漿市場：類型變異分析
  • 純 PRP
  • 富含白細胞的 Prp
  • 其他

第 6 章富血小板血漿市場 - 細分分析，按應用，2018-2030 年（百萬美元）

  • 富血小板血漿：應用變異分析
  • 骨科
  • 運動醫學
  • 整容手術
  • 皮膚科
    • 涵蓋的場景：美國的醫療保險和醫療補助服務中心
    • 潰瘍癒合
      • 靜脈潰瘍
      • 外傷性潰瘍
      • 壞疽性膿皮病潰瘍
      • 糖尿病潰瘍
      • 營養性潰瘍
      • 血管炎性潰瘍
    • 其他
  • 眼科
  • 神經外科
  • 普通外科
  • 其他

第 7 章富血小板血漿 (PRP) 市場 - 細分分析，按最終用途，2018-2030 年（百萬美元）

  • 富血小板血漿 (PRP)：最終用途變異分析
  • 醫院
  • 醫務室
  • 其他

第 8 章富血小板血漿 (PRP) 市場細分分析，按地區分列，2018-2030 年（百萬美元）

  • 富血小板血漿 (PRP) 市場：區域差異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 意大利
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中東和非洲
    • 南非
    • 阿拉伯聯合酋長國
    • 沙特阿拉伯

第 9 章公司簡介

  • 戰略框架
  • 市場參與的分類
  • 公司簡介
    • 強生公司
      • 公司簡介
      • DePuy 合成
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Arthrex, Inc.
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • EmCyte 公司
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • DR. PRP AMERICA, LLC
      • 公司簡介
      • 產品基準
    • 尤文蒂斯
      • 公司簡介
      • 財務表現
      • 產品基準
    • 泰爾茂公司
      • 公司簡介
      • 泰爾茂 BCT 有限公司
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Zimmer Biomet
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 史崔克
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • Apex Biologix
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
    • 細胞生物科學
      • 公司簡介
      • 財務表現
      • 產品基準
      • 戰略舉措
Product Code: GVR-1-68038-869-5

Platelet Rich Plasma Market Growth & Trends:

The global platelet rich plasma market size is expected to reach USD 1.94 billion by 2030, registering a CAGR of 15.11% from 2022 to 2030, according to a new report by Grand View Research, Inc. Rising number of cosmetic surgeries, increasing national and international sporting events, and extending research in plasma-based therapies are fueling the industry growth. Furthermore, R&D activities and regulatory approvals of platelet rich plasma (PRP) based treatments are key market drivers.

Currently, there has been an upsurge in demand for use of PRP in the treatment of sports injuries, orthopedic disorders, and musculoskeletal conditions. It concentrates on growth factors and can significantly reduce healing time. PRP also finds major application in the regenerative medicine field and serves as a custom product for each patient speeding up wound healing and repair cascade.

Platelet rich plasma has evolved in plastic surgery with promising results to utilize the body's own natural tissue repair process to achieve improved form and function. The characteristics such as ease of use, inexpensive to produce utilizing patient's cells, and little or no risk of adverse reactions are the main advantages offered by PRP therapies. However, treatment has been time consuming and requires multiple sessions. Moreover, it helps in skin rejuvenation, skin pigmentation, treating acne scars, and skin tightening during vampire facials. PRP is used as a supplement for hair transplant, which helps in the formation and maintenance of hair follicles. Thus, the widespread uses of platelet rich plasma are anticipated to fuel industry growth.

Furthermore, the key players are implementing strategic initiatives such as mergers and acquisitions, product development, and business expansions to enter the market. In September 2021, Terumo BCT expanded its presence in Costa Rica with the opening of a new manufacturing facility in La Lima, Cartago, with the view to expand its customer base in the U.S. In February 2020, EmCyte Co. acquired Cellmedix Holdings LLC, with its Centrepid platelet concentrator system. This expanded the company's product portfolio and improved its market presence.

In light of COVID-19, the market witnessed a significant setback due to supply chain disruption, constraints in resource allocation, and hindrances in patient access activities, among other reasons. However, by January 2021, the market got stabilized and continue to normalize demand and supply, and users and patients regain access to platelet-rich plasma.

Platelet Rich Plasma Market Report Highlights:

  • By type, the pure platelet-rich plasma segment held the largest revenue share of over 50.0% in 2021 due to its widespread use across various therapeutic areas and rising demand for its off-label uses worldwide
  • By application, the orthopedics segment dominated the market in 2021 due to an upsurge in the number of research studies to investigate PRP across various applications in orthopedics. However, other segments such as dermatology, sports medicine, and ulcer healing are expected to grow at a faster rate over the forecast period
  • The hospitals end-use segment held the largest revenue share in 2021. This can be attributed to an increase in the number of hospitals delivering PRP-based therapies and rising number of knee osteoarthritis cases in recent years
  • North America dominated the global market in 2021 due to wider applications of RPP, rising awareness about PRP-based treatments, and increasing number of orthopedics incidences
  • Asia Pacific is expected to grow considerably in the future owing to rising number of cosmetic surgeries and growing medical tourism industry

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates and Forecast Timeline
  • 1.3 Information Procurement
  • 1.4 Research Methodology
  • 1.5 Information Procurement
    • 1.5.1 Purchased Database
    • 1.5.2 GVR's Internal Database
    • 1.5.3 Secondary Sources
    • 1.5.4 Primary Research
    • 1.5.5 Details of Primary Research
  • 1.6 Information or Data Analysis
    • 1.6.1 Platelet Rich Plasma (PRP) Market: segment revenue and growth analysis
    • 1.6.2 sports medicine market: segment revenue and growth analysis
    • 1.6.3 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment revenue and growth analysis
      • 1.6.3.1 Platelet Rich Plasma (PRP)-based ulcer healing Market: segment definition
      • 1.6.3.1.1 Non-Healing Ulcers
      • 1.6.3.1.1.1 Diabetic Ulcers
      • 1.6.3.1.1.2 Pressure Ulcers
      • 1.6.3.1.1.3 Pyoderma gangrenosum
      • 1.6.3.1.1.4 Venous ulcers
    • 1.6.4 Data Analysis Models
  • 1.7 Market Formulation & Validation
  • 1.8 Model Details
    • 1.8.1 Commodity Flow Analysis
      • 1.8.1.1 Approach 1: Commodity Flow Approach
      • 1.8.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.9 Market: CAGR Calculation
  • 1.10 List of Secondary Sources
  • 1.11 List of Primary Sources
  • 1.12 Objectives
    • 1.12.1 Objective 1
    • 1.12.2 Objective 2

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Market Summary

Chapter 4 Host Cell Contaminant Testing Market Variables, Trends & Scope

  • 4.1 Market Trends & Outlook
  • 4.2 Market Segmentation & Scope
  • 4.3 Market Driver Analysis
    • 4.3.1 Rise In The Incidence Of Orthopedic Disorders And Sports Injuries
    • 4.3.2 Increasing Regulatory Focus On Host Cell Contaminant Detection
    • 4.3.3 extending Medical Applications Of Platelet Rich Plasma
    • 4.3.4 Increasing Number Of Evidence-Based Studies For Prp-Based Wound Healing
  • 4.4 Market Restraint Analysis
    • 4.4.1 high Costs Associated With Prp Products
  • 4.5 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 4.6 Porter's Five Forces Analysis
  • 4.7 COVID-19 Impact Analysis
  • 4.8 Penetration & Growth Prospect Mapping

Chapter 5 Platelet Rich Plasma Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 5.1 Platelet Rich PlasmaMarket: Type Movement Analysis
  • 5.2 Pure PRP
    • 5.2.1 Pure Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 leukocyte Rich Prp
    • 5.3.1 leukocyte Rich Prpmarket Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Others
    • 5.4.1 Other Type Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Platelet Rich Plasma market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 6.1 platelet Rich Plasmamarket: Application Movement Analysis
  • 6.2 Orthopedics
    • 6.2.1 Orthopedics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Sports Medicine
    • 6.3.1 Sport Medicine market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Cosmetic Surgery
    • 6.4.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Cosmetic Surgery, 2018 - 2030
  • 6.5 Dermatology
    • 6.5.1 Coverage Scenario: U.S. Centers For Medicare & Medicaid Services
    • 6.5.2 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Dermatology, 2018 - 2030
    • 6.5.3 Ulcer healing
      • 6.5.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for ulcer healing, 2018 - 2030
      • 6.5.3.2 Venous ulcers
      • 6.5.3.2.1 Platelet Rich Plasma (PRP) Market estimates and forecast for venous ulcers, 2018 - 2030
      • 6.5.3.3 Traumatic ulcers
      • 6.5.3.3.1 Platelet Rich Plasma (PRP) Market estimates and forecast for traumatic ulcers, 2018 - 2030
      • 6.5.3.4 Pyoderma gangrenosum ulcers
      • 6.5.3.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030
      • 6.5.3.5 Diabetic ulcers
      • 6.5.3.5.1 Platelet Rich Plasma (PRP) Market estimates and forecast for diabetic ulcers, 2018 - 2030
      • 6.5.3.6 Trophic ulcers
      • 6.5.3.6.1 Platelet Rich Plasma (PRP) Market estimates and forecast for trophic ulcers, 2018 - 2030
      • 6.5.3.7 Vasculitic ulcers
      • 6.5.3.7.1 Platelet Rich Plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030
    • 6.5.4 Others
      • 6.5.4.1 Platelet Rich Plasma (PRP) Market estimates and forecast for others, 2018 - 2030
  • 6.6 Ophthalmic Surgery
    • 6.6.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Ophthalmic Surgery, 2018 - 2030
  • 6.7 Neurosurgery
    • 6.7.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Neurosurgery, 2018 - 2030
  • 6.8 General Surgery
    • 6.8.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For General Surgery, 2018 - 2030
  • 6.9 Others
    • 6.9.1 Platelet Rich Plasma (Prp) Market Estimates And Forecast For Others, 2018 - 2030

Chapter 7 Platelet Rich Plasma (PRP) Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)

  • 7.1 Platelet Rich Plasma (PRP): End-use Movement Analysis
  • 7.2 Hospitals
    • 7.2.1 Hospitals market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Clinics
    • 7.3.1 Clinics market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Others
    • 7.4.1 Others market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Platelet Rich Plasma (PRP) Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 8.1 Platelet Rich Plasma (PRP) Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 Spain
      • 8.3.4.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 France
      • 8.3.5.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Italy
      • 8.3.6.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.6 Australia
      • 8.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East And Africa
    • 8.6.1 Middle-East And Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 UAE
      • 8.6.3.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.4 Saudi Arabia
      • 8.6.4.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Company Profile

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Company Profiles
    • 9.3.1 Johnson & Johnson
      • 9.3.1.1 Company overview
      • 9.3.1.2 DePuy Synthes
      • 9.3.1.2.1 Company overview
      • 9.3.1.3 Financial Performance
      • 9.3.1.4 Product benchmarking
      • 9.3.1.5 Strategic initiatives
    • 9.3.2 Arthrex, Inc.
      • 9.3.2.1 Company overview
      • 9.3.2.2 Financial Performance
      • 9.3.2.3 Product benchmarking
      • 9.3.2.4 Strategic initiatives
    • 9.3.3 EmCyte Corporation
      • 9.3.3.1 Company overview
      • 9.3.3.2 Product benchmarking
      • 9.3.3.3 Strategic initiatives
    • 9.3.4 DR. PRP AMERICA, LLC
      • 9.3.4.1 Company overview
      • 9.3.4.2 Product benchmarking
    • 9.3.5 Juventix
      • 9.3.5.1 Company overview
      • 9.3.5.2 Financial Performance
      • 9.3.5.3 Product benchmarking
    • 9.3.6 Terumo Corporation
      • 9.3.6.1 Company overview
      • 9.3.6.2 TERUMO BCT, INC.
      • 9.3.6.2.1 Company overview
      • 9.3.6.3 Financial Performance
      • 9.3.6.4 Product benchmarking
      • 9.3.6.5 Strategic initiatives
    • 9.3.7 Zimmer Biomet
      • 9.3.7.1 Company overview
      • 9.3.7.2 Financial Performance
      • 9.3.7.3 Product benchmarking
      • 9.3.7.4 Strategic initiatives
    • 9.3.8 Stryker
      • 9.3.8.1 Company overview
      • 9.3.8.2 Financial Performance
      • 9.3.8.3 Product benchmarking
      • 9.3.8.4 Strategic initiatives
    • 9.3.9 Apex Biologix
      • 9.3.9.1 Company overview
      • 9.3.9.2 Financial Performance
      • 9.3.9.3 Product benchmarking
      • 9.3.9.4 Strategic initiatives
    • 9.3.10 Celling Biosciences
      • 9.3.10.1 Company overview
      • 9.3.10.2 Financial Performance
      • 9.3.10.3 Product benchmarking
      • 9.3.10.4 Strategic initiatives

List of Tables

  • Table 1 Global Platelet Rich Plasma (PRP) Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 3 Global Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 4 Global Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 5 North America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 North America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 8 North America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 U.S. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 12 Canada Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 Canada Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15 Europe Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 16 Europe Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Europe Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 18 Europe Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 19 U.K. Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 U.K. Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 U.K. Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22 Germany Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Germany Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 25 France Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 France Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 France Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 28 Italy Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Italy Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 Italy Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 31 Spain Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Spain Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Spain Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 38 Japan Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Japan Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 40 Japan Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 41 China Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 China Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 43 China Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 44 India Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 India Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 46 India Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 47 Australia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Australia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Australia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 50 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 South Korea Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 53 Latin America Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 54 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 56 Latin America Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 57 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 59 Brazil Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 60 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 62 Mexico Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 63 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Country, 2018 - 2030 (USD Million)
  • Table 64 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 69 South Africa Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 70 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 71 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 72 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)
  • Table 73 UAE Platelet Rich Plasma (PRP) Market, By Type, 2018 - 2030 (USD Million)
  • Table 74 UAE Platelet Rich Plasma (PRP) Market, By Application, 2018 - 2030 (USD Million)
  • Table 75 UAE Platelet Rich Plasma (PRP) Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 PRP segment revenue modeling
  • Fig. 5 Sports medicine market segment revenue modeling
  • Fig. 6 PRP-based ulcer healing market: Segment revenue modeling
  • Fig. 7 Commercial viability and research base for PRP-based treatment of non-healing ulcer
  • Fig. 8 Market research approaches
  • Fig. 9 Value chain-based sizing & forecasting
  • Fig. 10 QFD modeling for market share assessment
  • Fig. 11 Market formulation & validation
  • Fig. 12 Platelet rich plasma (PRP) market snapshot, 2021 (USD Million)
  • Fig. 13 Platelet rich plasma (PRP) market segmentation
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
  • Fig. 16 Incidence of arthritis in U.S., by age
  • Fig. 17 Incidence of osteoarthritis in the UK, 2019 (%)
  • Fig. 18 Benefits of PRP treatment in cosmetic facial procedures
  • Fig. 19 Common cosmetic surgical procedures in 2019
  • Fig. 20 Cosmetic plastic demographic data in 2019
  • Fig. 21 Common minimal invasive procedures in 2019, U.S.
  • Fig. 22 Number of customers for cosmetic surgery in China (Million)
  • Fig. 23 Number of cosmetic procedures in 2016 (Thousand)
  • Fig. 24 Market restraint relevance analysis (Current & future impact)
  • Fig. 25 Market opportunity relevance analysis (Current & future impact)
  • Fig. 26 Penetration and growth prospect mapping, by Application, 2021
  • Fig. 27 Platelet rich plasma (PRP) market SWOT analysis
  • Fig. 28 Platelet rich plasma (PRP) market Porter's five forces analysis
  • Fig. 29 Platelet rich plasma (PRP) market: Type outlook and key takeaways
  • Fig. 30 Platelet rich plasma (PRP) market: Type movement analysis
  • Fig. 31 Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Leukocyte rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 34 Platelet rich plasma (PRP) market: Application outlook and key takeaways
  • Fig. 35 Platelet rich plasma (PRP) market: Application movement analysis
  • Fig. 36 Platelet rich plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
  • Fig. 37 Platelet rich plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
  • Fig. 38 Platelet rich plasma (PRP) Market estimates and forecast for cosmetic surgery, 2018 - 2030 (USD Million)
  • Fig. 39 Platelet rich plasma (PRP) market estimates and forecast for dermatology, 2018 - 2030 (USD Million)
  • Fig. 40 Reduction in the mean surface area of non-healing ulcers through 5 weeks
  • Fig. 41 Distribution of demographic parameter in patients with non-healing ulcers
  • Fig. 42 Categorization of studies based on types of ulcers
  • Fig. 43 Platelet rich plasma (PRP) market estimates and forecast for ulcer healing, 2018 - 2030 (USD Million)
  • Fig. 44 Meta-analysis of lower extremity venous ulcers
  • Fig. 45 Platelet rich plasma (PRP) market estimates and forecast for venous ulcers, 2018 - 2030 (USD Million)
  • Fig. 46 Platelet rich plasma (PRP) market estimates and forecast for traumatic ulcers, 2018 - 2030 (USD Million)
  • Fig. 47 Platelet rich plasma (PRP) market estimates and forecast for pyoderma gangrenosum ulcers, 2018 - 2030 (USD Million)
  • Fig. 48 Results obtained for individuals treated with PRP-Part A
  • Fig. 49 Results obtained for individuals treated with PRP-Part B
  • Fig. 50 Results obtained for individuals treated with PRP-Part C
  • Fig. 51 Key details of the meta-analysis performed on lower extremity diabetic ulcers
  • Fig. 52 Platelet rich plasma (PRP) market estimates and forecast for diabetic ulcers, 2018 - 2030
  • Fig. 53 Reduction in the surface area of trophic ulcers
  • Fig. 54 Reduction in the surface area of trophic ulcers
  • Fig. 55 Platelet rich plasma (PRP) market estimates and forecast for trophic ulcers, 2018 - 2030
  • Fig. 56 Potential of autologous PRP in the management of non-healing vasculitic ulcers
  • Fig. 57 Platelet rich plasma (PRP) Market estimates and forecast for vasculitic ulcers, 2018 - 2030 (USD Million)
  • Fig. 58 Platelet rich plasma (PRP) Market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 59 Platelet rich plasma (PRP) market estimates and forecast for ophthalmic surgery, 2018 - 2030 (USD Million)
  • Fig. 60 Platelet rich plasma (PRP) market estimates and forecast for neurosurgery, 2018 - 2030 (USD Million)
  • Fig. 61 Platelet rich plasma (PRP) market estimates and forecast for general surgery, 2018 - 2030
  • Fig. 62 Platelet rich plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
  • Fig. 63 Platelet rich plasma (PRP) market: End-use outlook and key takeaways
  • Fig. 64 Platelet rich plasma (PRP) market: End-use movement analysis
  • Fig. 65 Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
  • Fig. 66 Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
  • Fig. 67 Platelet rich plasma (PRP) market for others, 2018 - 2030 (USD Million)
  • Fig. 68 Platelet rich plasma (PRP) market: Regional outlook and key takeaways
  • Fig. 69 Platelet rich plasma (PRP) market: Regional movement analysis
  • Fig. 70 Strategy framework
  • Fig. 71 Market participation categorization